Drugs / EPO
last change Jul 2019 re-read 2 minutes ago

EPO

Developed for
anemia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02189889 Comparator Apr 2013 → Jul 2019 anemia, cardiovascular disorder University of Texas Southwestern Medical Center Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EPO ClinicalTrials.gov intervention name — accepted as the source's own label NCT02189889
Route Subcutaneous “a subcutaneous injection of EPO 300U/kg” NCT02189889